Jennifer McVige

Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine

Laszlo Mechtler, Nicolas Saikali, Jennifer McVige et al. · Frontiers in Neurology · 2022 · 59 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial

Brad Klein, Rosa Miceli, Lawrence Severt et al. · Cephalalgia · 2023 · 25 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Comparison of Remote Electrical Neuromodulation and Standard-Care Medications for Acute Treatment of Migraine in Adolescents: A Post Hoc Analysis

Andrew D. Hershey, Samantha Irwin, Liron Rabany et al. · Pain Medicine · 2021 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies

Todd J. Schwedt, Jae Lee, Kerry Knievel et al. · Journal of Managed Care & Specialty Pharmacy · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial

Richard B. Lipton, Rashmi B. Halker Singh, Laszlo Mechtler et al. · Cephalalgia · 2023 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16